BLX-0279

N/A

Report date: 2024/01/24 09:58:04
NME

Base Information

Drug NameBLX-0279
Drug Alias NameBLX-0279BLX 0279
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 6 modulators
TargetsHistone deacetylase 6
Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiolexis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiolexis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A